Hainan Shuangcheng Pharmaceuticals Co. Ltd. (002693)
Market Closed
11 Aug, 06:57
XSHE XSHE Primary ¥
9. 85
-0.1
-1.005%
¥
2.99B Market Cap
- P/E Ratio
0.4% Div Yield
25.74M Volume
- Eps
¥ 9.95
Previous Close Want to track 002693 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
002693 closed today lower at ¥9.85, a decrease of -1.005% from yesterday's close, completing a monthly increase of 5.1227% or ¥0.48. Over the past 12 months, 002693 stock gained 44.2167%.
002693 is not paying dividends to its shareholders.
The last earnings report, released on May 22, 2025, missed the consensus estimates by -0.0242%. On average, the company has fell short of earnings expectations by -0.1823%, based on the last three reports.
Hainan Shuangcheng Pharmaceuticals Co. Ltd. has completed 3 stock splits, with the recent split occurring on Mar 10, 2015.
The company's stock is traded on one exchange.
Hainan Shuangcheng Pharmaceuticals Co. Ltd. (002693) FAQ
What is the stock price today?
The current price is ¥9.85.
On which exchange is it traded?
Hainan Shuangcheng Pharmaceuticals Co. Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 002693.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.4%.
What is its market cap?
As of today, the market cap is 2.99B.
Has Hainan Shuangcheng Pharmaceuticals Co. Ltd. ever had a stock split?
Hainan Shuangcheng Pharmaceuticals Co. Ltd. had 3 splits and the recent split was on Mar 10, 2015.
Hainan Shuangcheng Pharmaceuticals Co. Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jianming Li CEO | XSHE Exchange | CNE100001K63 ISIN |
| CN Country | 605 Employees | 10 Mar 2015 Last Dividend | 22 May 2014 Last Split | 8 Aug 2012 IPO Date |
Overview
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is a prominent player within the pharmaceutical industry, known for its dedication to the research, development, manufacture, and global marketing of synthesized peptide drugs and active pharmaceutical ingredients. Since its establishment in the year 2000, the company has rapidly progressed to become a leading entity in the synthesis of peptide medications. Headquartered in Haikou, in the People's Republic of China, Hainan Shuangcheng Pharmaceuticals stands as a testament to innovation and excellence in the pharmaceutical sector.
Products and Services
- Somatostatin: A peptide that plays a crucial role in the inhibition of growth hormone, glucagon, and insulin, utilized for treating conditions such as acromegaly and gigantism.
- Thymosin: A substance pivotal in the stimulation of the immune system, used primarily in vaccines and treatments aimed at enhancing immunity.
- Clindamycin Hydrochloride: An active ingredient used for producing antibiotics to treat a variety of bacterial infections.
- Thymopentin: This peptide is designed to enhance immune function, especially in patients with immune deficiencies and autoimmune diseases.
- L-carnitine: A compound critical for energy production and fat metabolism, often used as a supplement for health and fitness.
- Uranin Hydrobromide: Mainly used in medical diagnostics and research applications.
- Inosine: A component used for its potential in nerve repair and cardiovascular treatments.
- Cyclophosphine Adenosine: An innovative compound under research for potential therapeutic applications.
- Motidine: Used in the treatment of certain stomach and throat problems by decreasing the amount of acid the stomach produces.
- Scopolamine: A medication used to treat motion sickness and postoperative nausea and vomiting.
- Sodium Ferulate: An antioxidant used in treatments aimed at reducing inflammation and protecting against heart disease.
- Vitamin B6: An essential vitamin used in various metabolic functions and often incorporated in supplements for general health maintenance.
Contact Information
Address: No. 16 Xingguo Road, Haikou, China, 570314
Phone: 86 898 6855 7717
Website: https://www.shuangchengmed.com
